A partir de cette page vous pouvez :
Retourner au premier écran avec les dernières notices... |
Descripteurs (mots clés)
Thésaurus Mesh
> O > Ostéomyélite
Ostéomyélite
Relation(s)
- voir aussi au terme générique : [Descripteurs (mots clés)] Infections osseuses
- voir aussi au terme spécifique : [Descripteurs (mots clés)] Mastoïdite
- voir aussi au terme spécifique : [Descripteurs (mots clés)] Pétrosite
- voir aussi au terme spécifique : [Descripteurs (mots clés)] Tumeur de Pott
Ajouter le résultat dans votre panier Affiner la recherche
Etendre la recherche sur niveau(x) vers le bas
Acquired calcaneus deformity secondary to osteomyelitis of the distal tibia / Davinder Singh in Journal of the American Podiatric Medical Association, vol.104, 1 (Janvier 2014)
[article]
in Journal of the American Podiatric Medical Association > vol.104, 1 (Janvier 2014) . - 95-98
Titre : Acquired calcaneus deformity secondary to osteomyelitis of the distal tibia Type de document : article de périodique Auteurs : Davinder Singh, Auteur ; Lovneesh G. Krishna, Auteur ; Jasbir Kaur, Auteur Article en page(s) : 95-98 Descripteurs (mots clés) : [Thésaurus Mesh]:C:Calcanéus:Calcanéus / malformations
[Thésaurus Mesh]Anomalies morphologiques du pied
[Thésaurus Mesh]Ostéomyélite
[Thésaurus Mesh]TibiaPermalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité Périodique Erasme - périodiques Périodiques Disponible Périodique Erasme - périodiques Périodiques Disponible Amputation versus Primary Nonoperative Management of Chronic Osteomyelitis Involving a Pedal Digit in Diabetic Patients / Viktor Feldman in Journal of the American Podiatric Medical Association, vol. 111, 04 (Juillet-aout 2021)
[article]
in Journal of the American Podiatric Medical Association > vol. 111, 04 (Juillet-aout 2021)
Titre : Amputation versus Primary Nonoperative Management of Chronic Osteomyelitis Involving a Pedal Digit in Diabetic Patients Type de document : article de périodique Auteurs : Viktor Feldman ; David Segal ; Ran Atzmon ; Itai Ron ; Meir Nyska ; Nissim Ohana ; Ezequiel Palmanovich Année de publication : 2021 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus Mesh]Amputation chirurgicale
[Thésaurus Mesh]Antibactériens
[Thésaurus Mesh]Orteils
[Thésaurus Mesh]Ostéomyélite
[Thésaurus Mesh]Pied diabétique
[Thésaurus Mesh]ThérapeutiqueRésumé : Background: The preferred primary treatment of toe osteomyelitis in diabetic patients is controversial. We compared the outcome of primary nonoperative antibiotic treatment versus digital amputation in patients with diabetes-related chronic digital osteomyelitis. Methods: We conducted a retrospective medical record review of patients treated for digital osteomyelitis at a single center. Patients were divided into two groups according to initial treatment: 1) nonoperative treatment with intravenous antibiotics and 2) amputation of the involved toe or ray. Duration of hospitalization, number of rehospitalizations, and rate of below- or above-the-knee major amputations were evaluated. Results: The nonoperative group comprised 39 patients and the operative group included 21 patients. The mean 6 SD total duration of hospitalization was 24.05 6 15.43 and 20.67 6 15.97 days, respectively (P ¼ .43). The mean 6 SD number of rehospitalizations after infection recurrence was 2.62 6 1.63 and 1.67 6 1.24, respectively (P ¼ .02). During follow-up, the involved digit was eventually amputated in 13 of the 39 nonoperatively treated patients (33.3%). The rate of major amputation (above- or below-knee amputation was four of 39 (10.3%) and three of 21 (14.3%), respectively (P ¼ .69). Conclusions: Despite a higher rate of rehospitalizations and a high failure rate, in patients with mild and limited digital foot osteomyelitis in the absence of sepsis it may be reasonable to offer a primary nonoperative treatment for digital osteomyelitis of the foot. (J Am Podiatr Med Assoc 111(4): 1-7, 2021) Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire An overview of the percutaneous antibiotic delivery technique for osteomyelitis treatment and a case study of calcaneal osteomyelitis / Jeffrey Karr in Journal of the American Podiatric Medical Association, vol. 107, 6 (Novembre -décembre 2017)
[article]
in Journal of the American Podiatric Medical Association > vol. 107, 6 (Novembre -décembre 2017) . - p. 511-515
Titre : An overview of the percutaneous antibiotic delivery technique for osteomyelitis treatment and a case study of calcaneal osteomyelitis Type de document : article de périodique Auteurs : Jeffrey Karr, Auteur Année de publication : 2017 Article en page(s) : p. 511-515 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus Mesh]:O:Ostéomyélite:Ostéomyélite / thérapie
[Thésaurus Mesh]Administration par voie intraveineuse
[Thésaurus Mesh]Antibactériens
[Thésaurus Mesh]Ostéomyélite
[Thésaurus Mesh]Présentations de cas
[Thésaurus Mesh]TalonMots-clés : administration, intravenous anti-bacterial agents osteomyelitis heel case reports Résumé : Background: A percutaneous antibiotic delivery technique (PAD-T) used for the adjunctive management of osteomyelitis is presented. Methods: This surgical technique incorporates a calcium sulfate and hydroxyapatite (calcium phosphate) bone void filler acting as a carrier vehicle with either an antibiotic or an antifungal medicine, delivering this combination directly into the area of osteomyelitis. Results: The benefit of the PAD-T is reviewed with a case presentation of a successfully treated calcaneal osteomyelitis. Conclusions: No previously reported PAD-T using a simple bone cortex incision in the adjunctive treatment of osteomyelitis has been reported. The PAD-T safely and effectively uses a calcium sulfate and hydroxyapatite bone void filler carrier vehicle to deliver either an antibiotic or an antifungal medicine directly into the area of osteomyelitis Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité J Périodique Erasme - périodiques Périodiques Disponible Are Surrogate Markers for Diabetic Foot Osteomyelitis Remission Reliable? / Peter A. Crisologo in Journal of the American Podiatric Medical Association, vol.111,05 (septembre-octobre 2021)
[article]
in Journal of the American Podiatric Medical Association > vol.111,05 (septembre-octobre 2021)
Titre : Are Surrogate Markers for Diabetic Foot Osteomyelitis Remission Reliable? Type de document : article de périodique Auteurs : Peter A. Crisologo ; Matthew Malone ; Javier La Fontaine ; Kavita Bhavan ; Adam Nichols ; Lawrence A. Lavery Année de publication : 0021 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Rémission
[Thésaurus Mesh]Infections des tissus mous
[Thésaurus Mesh]Marqueurs biologiques
[Thésaurus Mesh]Ostéomyélite
[Thésaurus Mesh]Pied diabétique
[Thésaurus Mesh]Revue de la littérature
[Thésaurus Mesh]Ulcère du piedRésumé : Background
We aimed to evaluate surrogate markers commonly used in the literature for diabetic foot osteomyelitis remission after initial treatment for diabetic foot infections (DFIs).
Methods
Thirty-five patients with DFIs were prospectively enrolled and followed for 12 months. Osteomyelitis was determined from bone culture and histologic analysis initially and for recurrence. Fisher exact and χ2 tests were used for dichotomous variables and Student t and Mann-Whitney U tests for continuous variables (α = .05).
Results
Twenty-four patients were diagnosed as having osteomyelitis and 11 as having soft-tissue infections. Four patients (16.7%) with osteomyelitis had reinfection based on bone biopsy. The success of osteomyelitis treatment varied based on the surrogate marker used to define remission: osteomyelitis infection (16.7%), failed wound healing (8.3%), reulceration (20.8%), readmission (16.7%), amputation (12.5%). There was no difference in outcomes among patients who were initially diagnosed as having osteomyelitis versus soft-tissue infections. There were no differences in osteomyelitis reinfection (16.7% versus 45.5%; P = .07), wounds that failed to heal (8.3% versus 9.1%; P = .94), reulceration (20.8% versus 27.3%; P = .67), readmission for DFIs at the same site (16.7% versus 36.4%; P = .20), amputation at the same site after discharge (12.5% versus 36.4%; P = .10). Osteomyelitis at the index site based on bone biopsy indicated that failed therapy was 16.7%. Indirect markers demonstrated a failure rate of 8.3% to 20.8%.
Conclusions
Most osteomyelitis markers were similar to markers in soft-tissue infection. Commonly reported surrogate markers were not shown to be specific to identify patients who failed osteomyelitis treatment compared with patients with soft-tissue infections. Given this, these surrogate markers are not reliable for use in practice to identify osteomyelitis treatment failure.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Are Surrogate Markers for Diabetic Foot Osteomyelitis Remission Reliable? / Peter A. Crisologo in Journal of the American Podiatric Medical Association, vol. 111, 05 (septembre-octobre 2021)
[article]
in Journal of the American Podiatric Medical Association > vol. 111, 05 (septembre-octobre 2021)
Titre : Are Surrogate Markers for Diabetic Foot Osteomyelitis Remission Reliable? Type de document : article de périodique Auteurs : Peter A. Crisologo ; Matthew Malone ; Javier La Fontaine ; Kavita Bhavan ; Adam Nichols ; Lawrence A. Lavery Année de publication : 2021 Langues : Anglais (eng) Descripteurs (mots clés) : [Thésaurus HELB]:Paramédical:Rémission
[Thésaurus Mesh]Marqueurs biologiques
[Thésaurus Mesh]Ostéomyélite
[Thésaurus Mesh]Pied diabétiqueRésumé : Background
We aimed to evaluate surrogate markers commonly used in the literature for diabetic foot osteomyelitis remission after initial treatment for diabetic foot infections (DFIs).
Methods
Thirty-five patients with DFIs were prospectively enrolled and followed for 12 months. Osteomyelitis was determined from bone culture and histologic analysis initially and for recurrence. Fisher exact and χ2 tests were used for dichotomous variables and Student t and Mann-Whitney U tests for continuous variables (α = .05).
Results
Twenty-four patients were diagnosed as having osteomyelitis and 11 as having soft-tissue infections. Four patients (16.7%) with osteomyelitis had reinfection based on bone biopsy. The success of osteomyelitis treatment varied based on the surrogate marker used to define remission: osteomyelitis infection (16.7%), failed wound healing (8.3%), reulceration (20.8%), readmission (16.7%), amputation (12.5%). There was no difference in outcomes among patients who were initially diagnosed as having osteomyelitis versus soft-tissue infections. There were no differences in osteomyelitis reinfection (16.7% versus 45.5%; P = .07), wounds that failed to heal (8.3% versus 9.1%; P = .94), reulceration (20.8% versus 27.3%; P = .67), readmission for DFIs at the same site (16.7% versus 36.4%; P = .20), amputation at the same site after discharge (12.5% versus 36.4%; P = .10). Osteomyelitis at the index site based on bone biopsy indicated that failed therapy was 16.7%. Indirect markers demonstrated a failure rate of 8.3% to 20.8%.
Conclusions
Most osteomyelitis markers were similar to markers in soft-tissue infection. Commonly reported surrogate markers were not shown to be specific to identify patients who failed osteomyelitis treatment compared with patients with soft-tissue infections. Given this, these surrogate markers are not reliable for use in practice to identify osteomyelitis treatment failure.Permalink : https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= [article]Exemplaires
Cote Support Localisation Section Disponibilité aucun exemplaire Chronic recurrent multifocal osteomyelitis : the prevalence of lower-limb and foot involvement / Jill Ferrari in Journal of the American Podiatric Medical Association, vol.104, 6 (Novembre 2014)
PermalinkChronic sclerosing osteomyelitis of Garré affecting fifth metatarsal bone of the foot / I.; G.r. Sharma; Taylor in The Foot, 4 (Décembre 2003)
PermalinkDecreasing hospital length of stay for patients with osteomyelitis: could early discharge be beneficial? / David C. Hatch in Podiatry today, vol. 31, 3 (Mars 2018)
PermalinkDecreasing Osteomyelitis Occurrence in Remaining Bone After Partially Resected Infected Bone / Jeffrey C. Karr in Journal of the American Podiatric Medical Association, vol. 112, 06 (Novembre 2022)
PermalinkEffect of Sensory Neuropathy on the Predictive Value of Inflammatory Biomarkers for Osteomyelitis in Diabetic and Nondiabetic Patients with Foot Infections / Easton Ryan in Journal of the American Podiatric Medical Association, vol. 112, 02 (Avril-juin 2022)
PermalinkFlag flap for coverage of a skin defect caused after debridement of chronic osteomyelitis of the proximal phalanx of the 5th toe / M. Aoki in The Foot, 4 (Décembre 2003)
PermalinkFunctional reconstruction of a calcaneal deficit due to osteomyelitis with femoral head and tendon rebalance / Brian, G. Loder in The Foot, vol.24, 3 (Septembre 2014)
PermalinkImproving Outcomes for Osteomyelitis After Partial Bone Resection A Preliminary Report / Jeffrey C. Karr in Journal of the American Podiatric Medical Association, Vol. 111, 03 (Mai-juin 2021)
PermalinkInfections ostéo-articulaires de l’enfant / Stéphanie Pannier in La revue du praticien, vol.66, 1 (Janvier 2016)
PermalinkInvasive squamous cell carcinoma with osteomyelitis of the foot : A case report / Nisha Shah in Journal of the American Podiatric Medical Association, vol.105, 4 (Juillet, Août 2015)
PermalinkIs the Anterolateral Thigh Flap the Solution for Orthopedic Trauma Complication Reconstructions? A Case Series in Journal of the American Podiatric Medical Association, vol. 112, 06 (Novembre 2022)
PermalinkIsolated tuberculosis of talus, an extremely rore occurrence / Mohamed H. Ebrahimzadeh in The Foot, vol.15, 1 (Mars 2005)
PermalinkIsolated tuberculous osteomyelitis of the talonavicular joint without pulmonary involvement : a rare case report / Wystan Chevannes in The Foot, vol.25, 1 (Mars 2015)
PermalinkLocalisation secondaire atypique d'une bactériémie à Staphylococcus aureus / Lisa Michelin in La revue de gériatrie, Vol. 47,07 (Septembre 2022)
PermalinkLower-extremity osteomyelitis treatment using calcium sulfate/hydroxyapatite bone void filler with antibiotics / Jeffrey Karr in Journal of the American Podiatric Medical Association, vol. 108, 3 (Mai - juin 2018)
PermalinkMetastatic gastric adenocarcinoma mimicking osteomyelitis of second toe / Gopikrishna Kakarala in The Foot, vol.18, 3 (Septembre 2008)
PermalinkMore Specialties, Fewer Problems Using Collaborative Competency Between Infectious Diseases, Podiatry, and Pathology to Improve the Care of Patients with Diabetic Foot Osteomyelitis / Vimal V. Jhaveri in Journal of the American Podiatric Medical Association, vol. 112, 06 (Novembre 2022)
PermalinkNovel Technique for the Treatment of a Tongue-Type Calcaneal Fracture in the Setting of Chronic Osteomyelitis / Mark Capuzzi in Journal of the American Podiatric Medical Association, Vol. 111, 03 (Mai-juin 2021)
PermalinkPoint-counterpoint: are oral antibiotics better than iv antibiotics for osteomyelitis? / Andrew J. Meyr in Podiatry today, vol.32, 2 (Février 2019)
PermalinkPrimary Invasive Squamous Cell Carcinoma of the Foot: A Case Report / Jordan Henning in Journal of the American Podiatric Medical Association, vol. 110, 04 (Juillet-aout 2020)
PermalinkReevaluating magnetic resonance imaging in radiographically suspected osteomyelitis of the toe / Nicholas Ciotola in Journal of the American Podiatric Medical Association, vol. 108, 6 (Novembre - décembre 2018)
PermalinkRisk factors for below-the-knee amputation in diabetic foot osteomyelitis after minor amputation / Whitney Miller in Journal of the American Podiatric Medical Association, vol. 109, 02 (Mars-avril 2019)
PermalinkRole of 99mTc MDP bone and Gallium imaging in evaluation of diabetic osteopathy / Shanmuga Sundaram in The Foot, vol.17, 2 (Juin 2007)
PermalinkSepticémie à kingella kingae chez une patiente présentant une infection à virus coxsackie / A. Huard in Revue médicale de Bruxelles, vol. 37, 5 (Septembre-octobre 2016)
PermalinkSingle stage treatment of diabetic calcaneal osteomyelitis with an absorbable gentamicin-loaded calcium sulphate/hydroxyapatite biocomposite: the Silo technique / Moez Balal in The Foot, 34 (Mars 2018)
PermalinkThe Clinical Value of Diffusion-Weighted Magnetic Resonance Imaging in Diabetic Foot Infection / Mehmet Ali Eren in Journal of the American Podiatric Medical Association, vol. 109, 04 (Juillet-août 2019)
PermalinkThe Degree of Blood Supply and Infection Control Needed to Treat Diabetic Chronic Limb-Threatening Ischemia with Forefoot Osteomyelitis / Miki Fujii in Journal of the American Podiatric Medical Association, vol. 111, 02 (Mars-avril 2021)
PermalinkTuberculosis infection of the talonavicular joint / C.J. Brew in The Foot, vol.20, 4 (Décembre 2010)
PermalinkUse of a Skin-Covering Pocket as a Local Flap and Negative Pressure Wound Therapy with Instillation and Dwell Time/Negative Pressure Wound Therapy for the Treatment of Diabetic Foot Ulcer with Calcaneal Osteomyelitis: A Case Report / Misato Ueda in Journal of the American Podiatric Medical Association, vol.113, 05 (Septembre 2023)
Permalink